Contact
searchSearch
HMP Global
mechanical circulatory support

Impella-Supported High-Risk PCI: P3 and LOQI Findings in the Context of CHIP-BCIS3

Vasileios Panoulas, MD, PhD
11/02/2026

© 2026 HMP Global. All Rights Reserved.

Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Cath Lab Digest or HMP Global, their employees, and affiliates. 

In this video at TCT 2026, Dr. Vasileios Panoulas discusses mortality findings from PROTECT III (P3) and the Long-Term Outcome and Quality Indicator (LOQI) Impella Registry in the context of CHIP-BCIS3 (presented at ACC.26).

P3 is a prospective, multicenter, single-arm observational study nested within the global cVAD registry. The LOQI registry tracks real-world outcomes in patients receiving Impella support.

Listen below for Dr. Panoulas' summary of the P3 study and LOQI registry, and key takeways:

Watch the Video

Vasileios Panoulas, MD, MSc, PhD, FRCP, FESC

Consultant Interventional Cardiologist and Director of Coronary Intervention for the Heart, Lung and Critical Care Clinical Group at Guy's and St Thomas' NHS Foundation Trust / Royal Brompton & Harefield hospitals;

Honorary Senior Clinical Lecturer at the National Heart & Lung Institute, Imperial College London.

Related Content

Escaned and Sandoval
CT-Guided PCI at TCT 2026
Reactions to the International Randomized P4 (Precise Procedural and PCI Plan) Trial
11/02/2026
Javier Escaned, MD, PhD; Yader Sandoval, MD
Professors Javier Escaned and Yader Sandoval, interventional cardiologists experienced in CT-guided PCI, share their thoughts on the P4 trial.
Professors Javier Escaned and Yader Sandoval, interventional cardiologists experienced in CT-guided PCI, share their thoughts on the P4 trial.
Professors Javier Escaned and...
11/02/2026
Cath Lab Digest
radiation safety
Lead-Free Shielding System Associated with Low Operator Radiation Exposure During Endovascular Procedures
11/02/2026
Multicenter study reports low operator radiation exposure across 95 sites using an alternative to traditional lead-apron protection.
Multicenter study reports low operator radiation exposure across 95 sites using an alternative to traditional lead-apron protection.
Multicenter study reports low...
11/02/2026
Cath Lab Digest
R-Star system (Robocath)
Robotic PCI
First-in-Human Coronary Intervention Study Results of Robocath’s Next-Generation Robotic System Highlighted at TCT
11/02/2026
The findings support a favorable performance profile for the system, with 100% clinical success rate and no device-related complications.
The findings support a favorable performance profile for the system, with 100% clinical success rate and no device-related complications.
The findings support a favorable...
11/02/2026
Cath Lab Digest
Electrocardiograms: AI
ALIGN-ACS: HeartBeam Announces Positive Heart Attack Pilot Study Results – Patient-Recorded 3D ECG Shown to Be as Accurate as Standard 12-Lead ECG
11/02/2026
HeartBeam’s portable, cable-free, credit-card-sized device enables patients to record their own ECG on-demand, wherever they are, including at home. Unlike conventional wearables, HeartBeam captures three-dimensional electrical information...
HeartBeam’s portable, cable-free, credit-card-sized device enables patients to record their own ECG on-demand, wherever they are, including at home. Unlike conventional wearables, HeartBeam captures three-dimensional electrical information...
HeartBeam’s portable,...
11/02/2026
Cath Lab Digest

Subscriber

Cath Lab Digest Newsletter

Clinical & Industry News

radiation safety
Lead-Free Shielding System Associated with Low Operator Radiation Exposure During Endovascular Procedures
11/02/2026
Multicenter study reports low operator radiation exposure across 95 sites using an alternative to traditional lead-apron protection.
Multicenter study reports low operator radiation exposure across 95 sites using an alternative to traditional lead-apron protection.
Multicenter study reports low...
11/02/2026
Cath Lab Digest
R-Star system (Robocath)
Robotic PCI
First-in-Human Coronary Intervention Study Results of Robocath’s Next-Generation Robotic System Highlighted at TCT
11/02/2026
The findings support a favorable performance profile for the system, with 100% clinical success rate and no device-related complications.
The findings support a favorable performance profile for the system, with 100% clinical success rate and no device-related complications.
The findings support a favorable...
11/02/2026
Cath Lab Digest
Left Atrial Appendage Occlusion
SIMPLAAFY Study: Less Intensive Antithrombotic Strategies Met Noninferiority Compared with DAPT After Left Atrial Appendage Closure
11/02/2026
New findings from the randomized SIMPLAAFY trial suggest that less intensive antithrombotic therapy following left atrial appendage closure (LAAC) with the WATCHMAN FLX™ Pro LAAC Device can reduce the risk of clinically-relevant bleeding...
New findings from the randomized SIMPLAAFY trial suggest that less intensive antithrombotic therapy following left atrial appendage closure (LAAC) with the WATCHMAN FLX™ Pro LAAC Device can reduce the risk of clinically-relevant bleeding...
New findings from the randomized...
11/02/2026
Cath Lab Digest
Tricuspid Valve Intervention
CLASP II TR Trial Demonstrates Superior Clinical, Quality-of-Life Benefits With Edwards PASCAL System
11/02/2026
Among the CLASP II TR patients treated with the PASCAL system, 80% achieved ≤ moderate TR at 1 year vs. 30% in the control group and showed a clinically significant 18-point improvement in patient quality-of-life measures as reported in the...
Among the CLASP II TR patients treated with the PASCAL system, 80% achieved ≤ moderate TR at 1 year vs. 30% in the control group and showed a clinically significant 18-point improvement in patient quality-of-life measures as reported in the...
Among the CLASP II TR patients...
11/02/2026
Cath Lab Digest
degenerative mitral valve disease
Global Burden of Degenerative Mitral Valve Disease Doubled Over 30 Years, with Worse Outcomes in Women and Low-Resource Areas
11/02/2026
In this analysis, the global prevalence of DMVD increased over the 30-year period by 126% to an estimated 16.1 million individuals, while deaths increased by 75% to 39,800. However, the age-standardized prevalence rate remained relatively...
In this analysis, the global prevalence of DMVD increased over the 30-year period by 126% to an estimated 16.1 million individuals, while deaths increased by 75% to 39,800. However, the age-standardized prevalence rate remained relatively...
In this analysis, the global...
11/02/2026
Cath Lab Digest
TAVR for Moderate AS
PROGRESS Trial: TAVR Improves Outcomes for Patients with Moderate Aortic Stenosis and At-Risk Features
11/02/2026
In a randomized trial of patients with moderate AS and at least one at-risk feature, those who underwent earlier TAVR had improved outcomes at two years than those managed with clinical surveillance.
In a randomized trial of patients with moderate AS and at least one at-risk feature, those who underwent earlier TAVR had improved outcomes at two years than those managed with clinical surveillance.
In a randomized trial of...
11/02/2026
Cath Lab Digest
Left Atrial Appendage Occlusion
VERITAS: Late-Breaking One-Year Data Show Abbott's Next-Generation Amulet 360™ Device Continues to Demonstrate High Rates of Left Atrial Appendage Closure and Low Incidence of Stroke
11/02/2026
Late-breaking one-year VERITAS study results were presented at TCT 2026; data show the device achieved high closure rates of the left atrial appendage (LAA) and a low incidence of stroke.
Late-breaking one-year VERITAS study results were presented at TCT 2026; data show the device achieved high closure rates of the left atrial appendage (LAA) and a low incidence of stroke.
Late-breaking one-year VERITAS...
11/02/2026
Cath Lab Digest
Electrocardiograms: AI
ALIGN-ACS: HeartBeam Announces Positive Heart Attack Pilot Study Results – Patient-Recorded 3D ECG Shown to Be as Accurate as Standard 12-Lead ECG
11/02/2026
HeartBeam’s portable, cable-free, credit-card-sized device enables patients to record their own ECG on-demand, wherever they are, including at home. Unlike conventional wearables, HeartBeam captures three-dimensional electrical information...
HeartBeam’s portable, cable-free, credit-card-sized device enables patients to record their own ECG on-demand, wherever they are, including at home. Unlike conventional wearables, HeartBeam captures three-dimensional electrical information...
HeartBeam’s portable,...
11/02/2026
Cath Lab Digest
Aortic Stenosis: AI
TCT 2026 Clinical Data Reveals 84% Reporting Gap in Aortic Valve Calcification, Highlighting the Potential of Nanox.AI’s AVC Solution
11/02/2026
Nanox.AI's Investigational AVC Solution Demonstrated 98.3% Sensitivity and 96.6% Specificity in Evaluable CT Scans. Findings Highlight the Potential of AI to Identify Previously Unreported Aortic Valve Calcification Using Existing Routine CT...
Nanox.AI's Investigational AVC Solution Demonstrated 98.3% Sensitivity and 96.6% Specificity in Evaluable CT Scans. Findings Highlight the Potential of AI to Identify Previously Unreported Aortic Valve Calcification Using Existing Routine CT...
Nanox.AI's Investigational AVC...
11/02/2026
Cath Lab Digest
CLINICAL Trials: LAAO
Late-Breaking One-Year Data Show Abbott’s Next-Gen Amulet 360 Device Continues to Demonstrate High Rates of Left Atrial Appendage Closure and Low Incidence of Stroke
11/02/2026
Late-breaking one-year VERITAS study results were presented at the Transcatheter Cardiovascular Therapeutics conference and simultaneously published in JACC: Cardiovascular Interventions; data show the device achieved high closure rates of...
Late-breaking one-year VERITAS study results were presented at the Transcatheter Cardiovascular Therapeutics conference and simultaneously published in JACC: Cardiovascular Interventions; data show the device achieved high closure rates of...
Late-breaking one-year VERITAS...
11/02/2026
Cath Lab Digest

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use